FIELD: medicine, pharmacy. SUBSTANCE: invention proposes an ointment comprising the following components, wt.%: pancreatin, 5; methyluracil, 3 as active components; polyethylene oxide-1500, 18.4; polyethylene oxide-400, 73.5 as a base; nypagine, 0.08 and nypazol, 0.02 as preserving agents. Invention can be used in production of drugs used in treatment of skin impairment. EFFECT: enhanced effectiveness of suppurative wounds treatment. 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
PHARMACEUTICAL COMPOSITION "OFLOMELID" FOR EXTERNAL APPLICATION IN PYOINFLAMMATORY DISEASE TREATMENT | 2007 |
|
RU2349302C1 |
PREPARATION FOR TREATMENT OF SURFACE AND DEEP WOUNDS | 1992 |
|
RU2033788C1 |
OINTMENT FOR BURNING AND INFECTED WOUND HEALING | 1999 |
|
RU2174389C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
SALICYLIC OINTMENT | 1995 |
|
RU2112506C1 |
Authors
Dates
2002-10-27—Published
2000-03-13—Filed